/
VOLUME 27  NUMBER 11 NOVEMBER 2009   NATURE BIOTECHNOLOGY VOLUME 27  NUMBER 11 NOVEMBER 2009   NATURE BIOTECHNOLOGY

VOLUME 27 NUMBER 11 NOVEMBER 2009 NATURE BIOTECHNOLOGY - PDF document

test
test . @test
Follow
404 views
Uploaded On 2015-11-30

VOLUME 27 NUMBER 11 NOVEMBER 2009 NATURE BIOTECHNOLOGY - PPT Presentation

Courts upbraid USDA for 145lax review146 of GM cropsA federal judge has ruled that the US Department of Agriculture USDA failed to adequately assess the environmental impact of Monsanto146s ID: 209594

Courts upbraid USDA for ‘lax

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "VOLUME 27 NUMBER 11 NOVEMBER 2009 NAT..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

VOLUME 27 NUMBER 11 NOVEMBER 2009 NATURE BIOTECHNOLOGY Courts upbraid USDA for ‘lax review’ of GM cropsA federal judge has ruled that the US Department of Agriculture (USDA) failed to adequately assess the environmental impact of Monsanto’s Roundup Ready sugar beets. Judge Jeffrey White of the Federal District Court for the Northern District of California ruled in September that the USDA should have better assessed the potential impact of genetically modified (GM) sugar beets on closely related crops, such as red table beets and Swiss chard. The court has ordered the agency to conduct Commercial planting of GM sugar beets is suspended.istockphoto/Jason Lugo Puerto Rico GM crop havenPuerto Rico has passed a new law designed to position the island as an agricultural biotech Mecca. Legislators passed the Law for the Promotion and Development of Agricultural Biotechnological Businesses, signed in August by Governor Luis Fortuño. The new law introduces financing incentives and a series of measures designed to ease the process by which biotech corporations obtain trade rights